Clinical Trials Sponsored by Rivlin Medical Group

Total 833 results

Maoxiang Group Jilin Pharmaceutical Co., Ltd.

Completed

The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Centennial Medical Group

Terminated

A Comparison of Computer Vision Based Approach vs. Dual Energy X-ray Absorptiometry Scan to Measure Body Fat Percentage

Health Behavior

United States
Boston Medical Group

Unknown

Radial Shockwave Therapy for Erectile Dysfunction

Erectile Dysfunction

Colombia
SouthCoast Medical Group

Completed

Quantitative EEG During PSG in Patients With and Without Fibromyalgia (FMQEEG-10-26)

Fibromyalgia

United States
Tokushukai Medical Group

Unknown

Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury (PREKIT)

Chronic Kidney Disease

Japan
Tokushukai Medical Group

Unknown

A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members

Renal Insufficiency | Kidney Stone | Ureteral Stricture | Kidney Neoplasm | Ureteral Tumor

Japan
Boston Medical Group

Recruiting

Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation

Premature Ejaculation

Colombia
Boston Medical Group

Completed

TPTNS for Treating Patients With Premature Ejaculation

Premature Ejaculation

Colombia
Boston Medical Group

Completed

Comparative Effectiveness and Safety of Three Protocols Usin Li-ESWT for Erectile Dysfunction

Erectile Dysfunction

Colombia, Mexico
Boston Medical Group

Terminated

Low-intensity Extracorporeal Shock Wave for Erectile Disfunction

Erectile Dysfunction
Tokushukai Medical Group

Unknown

A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties

Kidney Neoplasms | Renal Insufficiency | Renal Replacement Therapy

Japan
Dexa Medica Group

Recruiting

DLBS2411 Treatment For Functional Dyspepsia

Functional Dyspepsia

Indonesia
Dexa Medica Group

Terminated

DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers

Non-Bleeding Peptic Ulcers

Indonesia
Dexa Medica Group

Terminated

DLBS1033 for the Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke

Indonesia
Dexa Medica Group

Completed

Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg

Healthy

Indonesia
Dexa Medica Group

Completed

Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

Indonesia
Dexa Medica Group

Completed

Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition

Healthy

Indonesia
Dexa Medica Group

Completed

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

Type-2 Diabetes Mellitus

Indonesia
Dexa Medica Group

Completed

Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients

Breast Cancer

Indonesia
Dexa Medica Group

Terminated

Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer

Breast Cancer

Indonesia
Dexa Medica Group

Completed

Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

Healthy

Indonesia
Dexa Medica Group

Completed

Safety and Efficacy of DLBS1033 in Healthy Subjects

Healthy

Indonesia
Dexa Medica Group

Completed

Efficacy and Safety of DLBS3233 in Prediabetic Patients (DIPPER-DM)

Prediabetic

Indonesia
Dexa Medica Group

Completed

DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis

Endometrioma | Visual Analogue Pain Scale: Moderate or Severe Pain

Indonesia
Dexa Medica Group

Withdrawn

DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization

Acute Non-ST Elevation Myocardial Infarction

Indonesia
Dexa Medica Group

Completed

Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg

Healthy

Indonesia
Dexa Medica Group

Completed

Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

Healthy

Indonesia
Dexa Medica Group

Completed

Bioequivalence Study of 4 mg Glimepiride Tablet

Glimepiride BE Study in Healthy Volunteers Under Fasting Condition

Indonesia
Dexa Medica Group

Completed

Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet

Metformin XR BE Study in Healthy Volunteers With Single and Multiple Dose

Indonesia
Dexa Medica Group

Completed

Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus

Diabetes Mellitus, Type 2

Indonesia
Dexa Medica Group

Terminated

DLBS1033 for Acute Ischemic Stroke Patients (ADDLIST)

Acute Ischemic Stroke | Partial Anterior Circulation Infarct | Lacunar Anterior Circulation Infarct

Indonesia
Dexa Medica Group

Terminated

Efficacy and Safety of DLBS2411 in the Management of GERD

Gastroesophageal Reflux Disease (GERD)

Indonesia
Dexa Medica Group

Completed

PCOS Treatment Using DLBS3233, Metformin, and Combination of Both (POSITIF)

Insulin Resistance | Polycystic Ovary Syndrome (PCOS)

Indonesia
Dexa Medica Group

Completed

Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS)

Indonesia
Dexa Medica Group

Terminated

DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease

Diabetes | Peripheral Arterial Disease

Indonesia
Dexa Medica Group

Withdrawn

DLBS1449 in Diabetic Patients With Low HDL

Diabetic Patients | Low HDL-cholesterol (< 35 mg/dL) | Lifestyle Intervention for at Least 1 Month

Indonesia
Dexa Medica Group

Completed

Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Indonesia
Dexa Medica Group

Completed

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

Type-2-diabetes Mellitus | New Onset

Indonesia
Dexa Medica Group

Completed

Efficacy and Safety of DLBS2411 in Healthy Volunteers

Gastric pH Regulation in Healthy Volunteers

Indonesia
Qingdao Hiser Medical Group

Recruiting

A Prospective, Multicenter, Observational Study on the Treatment of Chronic Common Femoral Artery Bifurcation Occlusion (EAST-CFA)

Common Femoral Artery Occlusive Disease

China
Qingdao Hiser Medical Group

Not yet recruiting

The Acute and Long-term Clinical Outcome of Self- Expandable Stent in Complex Proximal Superficial Femoral Artery Lesions Involving the Femoral Bifurcation

Common Femoral Artery Occlusive Disease
Obstetrix Medical Group

Completed

Optimal Management of Vasa Previa Study - A Retrospective Study (VasaPrevia)

Vasa Previa

United States
ArtVentive Medical Group, Inc.

Unknown

Evaluation of PerformanCe of the Peripheral EOS in the Treatment of Varicocele or Pelvic Congestion SynDromE (OCCLUDE-I)

Varicocele | Pelvic Congestion Syndrome

Belgium, Poland, Switzerland
ArtVentive Medical Group, Inc.

Unknown

Evaluation of Peripheral EOS for the Peripheral Embolization Treatment to Rapidly OccluDe Venous or Arterial BleEding (OCCLUDE-II)

Hemorrhage | Bleeding

Austria, Belgium, Germany
Obstetrix Medical Group

Withdrawn

Cerclage for Prevention on Preterm Birth in Women With Placenta Previa

Premature Birth | Placenta Previa
Redwood Regional Medical Group

Completed

High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes

Melanoma

United States
Moy-Fincher Medical Group

Unknown

The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure

Scars

United States
Yes Skin Medical Group

Recruiting

A Clinical Study to Evaluate the Efficacy and Satisfaction of Ultrasound Therapy Combined With SkinCeuticals A.G.E for Improving Facial Aging

Skin Aging

China
Obstetrix Medical Group

Completed

Maternal Uterine Artery Doppler Study

Maternal-Fetal Exchange

United States
Obstetrix Medical Group

Terminated

Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM) (PROMCerclage)

Fetal Membranes, Premature Rupture

United States

3

Subscribe